Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07308704 · ClinicalTrials.gov registry record
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 10,040,000
- Enrollment target
NCT07308704: Recruiting study, sponsored by Mayo Clinic.
NCT07308704 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10,040,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07308704 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 10,040,000 participants
- Enrollment target
Study Summary
The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usability, interpretive consistency, and workflow integration. Second, we will conduct a pragmatic, stepped-wedge clinical trial with multiple arms evaluating diagnostic AI-Echo algorithms designed to identify specific cardiovascular diseases- such as genetic cardiomyopathy, ischemic heart disease, and cardiac amyloidosis-and assess whether AI deployment increases diagnostic testing and shortens time to diagnosis. Trials will be conducted using EHR-based notification systems with cluster-level randomization.
Primary Outcome
Number of patients in the genetic cardiomyopathy arm who have a confirmed diagnosis of genetic cardiomyopathy based on genetic testing. Confirmation requires identification of a pathogenic or likely pathogenic variant in a cardiomyopathy-associated gene.
Interventions
- DIAGNOSTIC_TEST Transthoracic Echocardiography (TTE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,040,000 participants |
| Start Date | 2026-02-26 |
| Est. Completion | 2028-02 |
What NCT07308704 shows while recruiting
NCT07308704 is an observational study that tracks outcomes without assigning an intervention. Its 10,040,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Transthoracic Echocardiography (TTE) is the first listed.
NCT07308704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07308704 about?
NCT07308704 is a clinical study titled "A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation". The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usa...
What is the current status of trial NCT07308704?
This trial is currently recruiting. The enrollment target is 10,040,000 participants. The study started on 2026-02-26. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07308704?
The interventions under investigation include: Transthoracic Echocardiography (TTE) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07308704?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05678699 · 10,000,000 participants · NA
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
- NCT02693223 · 3,892,063 participants
Get With the Guidelines-Stroke Registry
- NCT06803498 · 3,000,000 participants
Delivery Room Intervention and Evaluation Network
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI